Skip to content

Mannkind MNKD Liability Sale For Future Royalties Current

Liability Sale For Future Royalties Current at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$305.04M+22.9%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.02B+9.3%
Geron logo
GeronGERN
$19.39M+24.8%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$72M+25.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.13B+42.1%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$100M0.0%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept mnkd:LiabilitySaleForFutureRoyaltiesCurrent.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's liability sale for future royalties current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's liability sale for future royalties current?
Mannkind (MNKD) reported liability sale for future royalties current of $14.01M in Q1 2026.
How has Mannkind's liability sale for future royalties current changed year-over-year?
Mannkind's liability sale for future royalties current increased by 9.4% year-over-year, from $12.8M to $14.01M.
What is the long-term trend for Mannkind's liability sale for future royalties current?
Over 2 years (2023 to 2025), Mannkind's liability sale for future royalties current has grown at a 21.1% compound annual growth rate (CAGR), from $9.76M to $14.3M.
What does liability sale for future royalties current mean?
This represents the current portion of obligations arising from the sale of future royalty streams to third-party investors in exchange for upfront capital. It reflects the company's commitment to pay out a portion of future product revenues within the next year. This metric highlights the impact of non-dilutive financing arrangements on short-term cash flow.